{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:01:27Z","timestamp":1781020887040,"version":"3.54.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.eprac.2026.03.001","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:54:08Z","timestamp":1773273248000},"page":"983-989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Endocrine Modulation of Inflammation: The Role of Adrenocorticotropic Hormone and Cortisol"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-5260","authenticated-orcid":false,"given":"Maritza","family":"Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2026.03.001_bib1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fendo.2019.00683","article-title":"Melanocortin regulation of inflammation","volume":"10","author":"Wang","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.eprac.2026.03.001_bib2","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1100\/tsw.2010.173","article-title":"The melanocortin system in control of inflammation","volume":"10","author":"Catania","year":"2010","journal-title":"Sci World J"},{"issue":"4","key":"10.1016\/j.eprac.2026.03.001_bib3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/er.2011-1016","article-title":"Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research","volume":"33","author":"B\u00f6hm","year":"2012","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.eprac.2026.03.001_bib4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1152\/physrev.2000.80.3.979","article-title":"Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress","volume":"80","author":"Slominski","year":"2000","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.001_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1389203720666191106113435","article-title":"The functional significance of endocrine-immune interactions in health and disease","volume":"21","author":"Muthusami","year":"2020","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.eprac.2026.03.001_bib6","series-title":"Endotext [Internet]","article-title":"Congenital adrenal hyperplasia","author":"Yau","year":"2000"},{"issue":"4","key":"10.1016\/j.eprac.2026.03.001_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin Neurosci"},{"issue":"3","key":"10.1016\/j.eprac.2026.03.001_bib8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/j.2040-4603.2015.tb00644.x","article-title":"Hypothalamic-pituitary-adrenal axis\u2014feedback control","volume":"5","author":"Keller-Wood","year":"2015","journal-title":"Compr Physiol"},{"issue":"2","key":"10.1016\/j.eprac.2026.03.001_bib9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/j.2040-4603.2016.tb00694.x","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response","volume":"6","author":"Herman","year":"2016","journal-title":"Compr Physiol"},{"issue":"5","key":"10.1016\/j.eprac.2026.03.001_bib10","first-page":"250","article-title":"Acthar gel and cosyntropin review: clinical and financial implications","volume":"34","author":"Gettig","year":"2009","journal-title":"P T"},{"issue":"4","key":"10.1016\/j.eprac.2026.03.001_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","article-title":"Long-term side effects of glucocorticoids","volume":"15","author":"Oray","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"10.1016\/j.eprac.2026.03.001_bib12","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1210\/er.2006-0034","article-title":"Studies on the physiological functions of the melanocortin system","volume":"27","author":"Cone","year":"2006","journal-title":"Endocr Rev"},{"issue":"10","key":"10.1016\/j.eprac.2026.03.001_bib13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0165-6147(02)02103-X","article-title":"Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy","volume":"23","author":"Getting","year":"2002","journal-title":"Trends Pharmacol Sci"},{"issue":"16","key":"10.1016\/j.eprac.2026.03.001_bib14","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.3390\/ijms21165728","article-title":"Structural complexity and plasticity of signaling regulation at the melanocortin-4 receptor","volume":"21","author":"Kleinau","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.eprac.2026.03.001_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-020-00435-w","article-title":"G protein-coupled receptors: structure- and function-based drug discovery","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"14","key":"10.1016\/j.eprac.2026.03.001_bib16","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3390\/cells12141889","article-title":"The melanocortin system in inflammatory bowel diseases: insights into its mechanisms and therapeutic potentials","volume":"12","author":"Gravina","year":"2023","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.eprac.2026.03.001_bib17","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1007\/s00018-020-03511-0","article-title":"Melanocortin-5 receptor signaling pathway in health and disease","volume":"77","author":"Xu","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.eprac.2026.03.001_bib18","series-title":"Endotext [Internet]","article-title":"ACTH action on the adrenals","author":"Angelousi","year":"2000"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.001_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/ph14010045","article-title":"Antifibrotic and anti-inflammatory actions of \u03b1-melanocytic hormone: new roles for an old player","volume":"14","author":"Dinparastisaleh","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.eprac.2026.03.001_bib20","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00296-020-04659-5","article-title":"Adrenocorticotropic hormone: an effective \u201cnatural\u201d biologic therapy for acute gout?","volume":"40","author":"Daoussis","year":"2020","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.eprac.2026.03.001_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2174\/1389203023380396","article-title":"Modulation of the peripheral and central inflammatory responses by \u03b1-melanocyte-stimulating hormone","volume":"3","author":"Oktar","year":"2002","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.eprac.2026.03.001_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/874610","article-title":"Alpha-melanocyte stimulating hormone: an emerging anti-inflammatory antimicrobial peptide","volume":"2014","author":"Singh","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.eprac.2026.03.001_bib23","article-title":"The alpha-melanocyte stimulating hormone induces conversion of effector T cells into Treg cells","volume":"2011","author":"Taylor","year":"2011","journal-title":"J Transpl"},{"key":"10.1016\/j.eprac.2026.03.001_bib24","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.2147\/JIR.S503621","article-title":"Dual role of \u03b1-MSH in colitis progression: mediating neutrophil differentiation via bone marrow","volume":"18","author":"Liao","year":"2025","journal-title":"J Inflamm Res"},{"issue":"5","key":"10.1016\/j.eprac.2026.03.001_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/biom14050525","article-title":"Alpha-melanocyte-stimulating hormone maintains retinal homeostasis after ischemia\/reperfusion","volume":"14","author":"Ng","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.eprac.2026.03.001_bib26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.smim.2015.02.003","article-title":"ACTH: the forgotten therapy","volume":"27","author":"Montero-Melendez","year":"2015","journal-title":"Semin Immunol"},{"issue":"9","key":"10.1016\/j.eprac.2026.03.001_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/diseases13090305","article-title":"Polymorphism of melanocortin receptor genes\u2014association with inflammatory traits and diseases","volume":"13","author":"Bardhan","year":"2025","journal-title":"Diseases"},{"key":"10.1016\/j.eprac.2026.03.001_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1084394","article-title":"Melanocortin therapies to resolve fibroblast-mediated diseases","volume":"13","author":"Khodeneva","year":"2023","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.eprac.2026.03.001_bib29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3390\/biom12101407","article-title":"Ligands for melanocortin receptors: beyond melanocyte-stimulating hormones and adrenocorticotropin","volume":"12","author":"Yuan","year":"2022","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.eprac.2026.03.001_bib30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40261-023-01303-5","article-title":"Acthar\u00ae gel treatment for patients with autoimmune and inflammatory diseases: an historical perspective and characterization of clinical evidence","volume":"43","author":"Kaplan","year":"2023","journal-title":"Clin Drug Investig"},{"issue":"3","key":"10.1016\/j.eprac.2026.03.001_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40744-023-00545-1","article-title":"A narrative review of acthar gel for the treatment of myositis","volume":"10","author":"Chandra","year":"2023","journal-title":"Rheumatol Ther"},{"issue":"10","key":"10.1016\/j.eprac.2026.03.001_bib32","first-page":"5094","article-title":"Activation of melanocortin type 3 receptor as a therapeutic target for anti-inflammatory peptides","volume":"147","author":"Getting","year":"2006","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.eprac.2026.03.001_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/10799893.2020.1818094","article-title":"Distinct binding and signaling activity of acthar gel compared to other melanocortin receptor agonists","volume":"41","author":"Huang","year":"2021","journal-title":"J Recept Signal Transduct Res"},{"issue":"11","key":"10.1016\/j.eprac.2026.03.001_bib34","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1007\/s12325-025-03359-5","article-title":"A narrative review of the immunomodulatory effects of acthar\u00ae Gel beyond its steroidogenic properties","volume":"42","author":"Mirsaeidi","year":"2025","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.eprac.2026.03.001_bib35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/jir.2022.0257","article-title":"Acthar gel inhibits the activation of CD4+ and CD8+ T cells","volume":"43","author":"Wright","year":"2023","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.eprac.2026.03.001_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/ard.8.2.97","article-title":"The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocortical hormone in arthritis: preliminary report","volume":"8","author":"Hench","year":"1949","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.001_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0002-9343(50)90004-0","article-title":"Effects of adrenocorticotropic hormone (ACTH) in gout","volume":"9","author":"Gutman","year":"1950","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.eprac.2026.03.001_bib38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jbspin.2012.09.009","article-title":"ACTH as first line treatment for acute gout in 181 hospitalized patients","volume":"80","author":"Daoussis","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.eprac.2026.03.001_bib39","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2026.03.001_bib40","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/archdischild-2015-308925","article-title":"A systematic review and meta-analysis of synacthen tests for assessing hypothalamic\u2013pituitary\u2013adrenal insufficiency in children","volume":"101","author":"Ng","year":"2016","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.001_bib41","article-title":"The comparison of the efficacy of intramuscular tetracosactide and subacromial triamcinolone injection in rotator cuff tendinitis: a randomized trial","volume":"9","author":"Orandi","year":"2025","journal-title":"Rheumatol Adv Pract"},{"issue":"6","key":"10.1016\/j.eprac.2026.03.001_bib42","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.5114\/aoms.2017.65650","article-title":"Comparative effects of methylprednisolone and tetracosactide (ACTH1-24) on ischemia\/reperfusion injury of the rabbit spinal cord","volume":"14","author":"Kertmen","year":"2018","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.eprac.2026.03.001_bib43","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10753-014-0029-5","article-title":"Melanocortin peptides: potential targets in systemic lupus erythematosus","volume":"38","author":"Loram","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.eprac.2026.03.001_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/IJNRD.S74349","article-title":"Low-dose synthetic adrenocorticotropic hormone-analog therapy for nephrotic patients: results from a single-center pilot study","volume":"8","author":"Lorusso","year":"2015","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.001_bib45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13075-022-02899-3","article-title":"Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis","volume":"24","author":"Kondo","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.eprac.2026.03.001_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512152","article-title":"Melanocortin 1 receptor (MC1R): pharmacological and therapeutic aspects","volume":"24","author":"Mun","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.eprac.2026.03.001_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ph17010031","article-title":"Illuminating dersimelagon: a novel agent in the treatment of erythropoietic protoporphyria and X-Linked protoporphyria","volume":"17","author":"Madigan","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.001_bib48","first-page":"101","article-title":"Repository corticotropin injection in patients with rheumatoid arthritis resistant to DMARDs: results from a randomized, double-blind, placebo-controlled withdrawal trial","volume":"7","author":"Fiechtner","year":"2020","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.eprac.2026.03.001_bib49","first-page":"13","article-title":"Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies","volume":"10","author":"Fischer","year":"2018","journal-title":"Open Access Rheumatol Res Rev"},{"key":"10.1016\/j.eprac.2026.03.001_bib50","first-page":"21","article-title":"Treatment with repository corticotropin injection in patients with rheumatoid arthritis, systemic lupus erythematosus, and dermatomyositis\/polymyositis","volume":"12","author":"Ho-Mahler","year":"2020","journal-title":"Open Access Rheumatol Res Rev"},{"issue":"2","key":"10.1016\/j.eprac.2026.03.001_bib51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/brainsci12020254","article-title":"Effectiveness of ACTH in patients with infantile spasms","volume":"12","author":"Paprocka","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.eprac.2026.03.001_bib52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0074-7742(02)49013-7","article-title":"ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability","volume":"49","author":"Brunson","year":"2002","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.eprac.2026.03.001_bib53","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10072-023-07078-z","article-title":"Treatment modalities for infantile spasms: current considerations and evolving strategies in clinical practice","volume":"45","author":"Hollenshead","year":"2024","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.001_bib54","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12348-024-00428-8","article-title":"Efficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases","volume":"14","author":"Yavari","year":"2024","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"21","key":"10.1016\/j.eprac.2026.03.001_bib55","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.3390\/jcm14217785","article-title":"Repository corticotropin therapy for refractory noninfectious inflammatory ocular diseases","volume":"14","author":"Nieves-R\u00edos","year":"2025","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.eprac.2026.03.001_bib56","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bone.2005.01.020","article-title":"Multiple melanocortin receptors are expressed in bone cells","volume":"36","author":"Zhong","year":"2005","journal-title":"Bone"},{"issue":"19","key":"10.1016\/j.eprac.2026.03.001_bib57","doi-asserted-by":"crossref","first-page":"8782","DOI":"10.1073\/pnas.0912176107","article-title":"ACTH protects against glucocorticoid-induced osteonecrosis of bone","volume":"107","author":"Zaidi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.eprac.2026.03.001_bib58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.2009.05231.x","article-title":"ACTH is a novel regulator of bone mass","volume":"1192","author":"Isales","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.001_bib59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s41030-022-00181-0","article-title":"Repository corticotropin injection for the treatment of pulmonary sarcoidosis: a narrative review","volume":"8","author":"Mirsaeidi","year":"2022","journal-title":"Pulm Ther"},{"issue":"7","key":"10.1016\/j.eprac.2026.03.001_bib60","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1007\/s12325-022-02160-y","article-title":"A narrative review of repository corticotropin injection for the treatment of systemic lupus erythematosus","volume":"39","author":"Askanase","year":"2022","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.eprac.2026.03.001_bib61","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/1056-8727(92)90037-L","article-title":"Severe hyperkalemia in two patients with diabetes after cosyntropin administration","volume":"6","author":"Feuerstein","year":"1992","journal-title":"J Diabetes Complications"},{"issue":"12","key":"10.1016\/j.eprac.2026.03.001_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061476","article-title":"Metabolic adverse events associated with systemic corticosteroid therapy: a systematic review and meta-analysis","volume":"12","author":"Kulkarni","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.eprac.2026.03.001_bib63","first-page":"175","article-title":"Insulin-releasing effects of adrenocorticotropin (ACTH 1-39) and ACTH fragments (1-24 and 18-39) in lean and genetically obese hyperglycaemic (ob\/ob) mice","volume":"11","author":"Bailey","year":"1987","journal-title":"Int J Obes"},{"issue":"3","key":"10.1016\/j.eprac.2026.03.001_bib64","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1677\/JOE-07-0299","article-title":"Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes","volume":"196","author":"Iwen","year":"2008","journal-title":"J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.001_bib65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1677\/joe.0.1800155","article-title":"ACTH stimulates insulin secretion from MIN6 cells and primary mouse and human islets of langerhans","volume":"180","author":"Al-Majed","year":"2004","journal-title":"J Endocrinol"},{"key":"10.1016\/j.eprac.2026.03.001_bib66","series-title":"Statpearls [Internet]","article-title":"Adrenocorticotropic hormone (cosyntropin) stimulation test","author":"Khare","year":"2025"},{"issue":"11","key":"10.1016\/j.eprac.2026.03.001_bib67","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/acn3.50922","article-title":"Effectiveness of corticosteroids versus adrenocorticotropic hormone for infantile spasms: a systematic review and meta-analysis","volume":"6","author":"Chang","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"10.1016\/j.eprac.2026.03.001_bib68","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1352458512458844","article-title":"Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis","volume":"19","author":"Arnason","year":"2013","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.eprac.2026.03.001_bib69","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrneph.2011.190","article-title":"The renaissance of corticotropin therapy in proteinuric nephropathies","volume":"8","author":"Gong","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.eprac.2026.03.001_bib70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jdv.20269","article-title":"An overview of benefits and risks of chronic melanocortin-1 receptor activation","volume":"39","author":"B\u00f6hm","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.eprac.2026.03.001_bib71","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/pcmr.12257","article-title":"MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation","volume":"27","author":"Garc\u00eda-Borr\u00f3n","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"10.1016\/j.eprac.2026.03.001_bib72","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00296-022-05128-x","article-title":"ACTH vs steroids for the treatment of acute gout in hospitalized patients: a randomized, open label, comparative study","volume":"42","author":"Daoussis","year":"2022","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.eprac.2026.03.001_bib73","doi-asserted-by":"crossref","first-page":"50","DOI":"10.36469\/jheor.2025.142078","article-title":"Cost per response of acthar\u00ae gel vs standard of care for the treatment of proteinuria in nephrotic syndrome due to idiopathic membranous nephropathy among adults from the US healthcare perspective","volume":"12","author":"Bindra","year":"2025","journal-title":"J Health Econ Outcomes Res"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26008074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26008074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:28:13Z","timestamp":1781018893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26008074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1530891X26008074"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.03.001","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine Modulation of Inflammation: The Role of Adrenocorticotropic Hormone and Cortisol","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}